<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36731604</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1916-7075</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Canadian journal of cardiology</Title><ISOAbbreviation>Can J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context.</ArticleTitle><Pagination><StartPage>779</StartPage><EndPage>792</EndPage><MedlinePgn>779-792</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjca.2023.01.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0828-282X(23)00068-5</ELocationID><Abstract><AbstractText>After the first confirmed case in 2019, COVID-19 rapidly spread worldwide and overwhelmed the medical community. In the intervening time, we have learned about COVID-19's clinical manifestations and have developed effective therapies and preventative vaccines. Severe COVID-19 infection is associated with many cardiovascular disorders in the acute phase, and patients recovered from illness can also manifest long-term sequelae, including long COVID syndrome. Furthermore, severe acute respiratory syndrome-related coronavirus-2 messenger RNA (mRNA) vaccination can trigger rare cases of myopericarditis. We have gained significant knowledge of the acute and long-term cardiovascular complications of COVID-19- and mRNA vaccine-associated myocarditis through clinical and investigative studies using cardiac imaging. In this review, we describe how cardiovascular imaging can be used to understand the cardiovascular complications and cardiac injury associated with acute COVID-19 infection, review the imaging findings in patients recovered from illness, and discuss the role and limitations of cardiac imaging in COVID-19 mRNA vaccine-associated myocarditis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crosier</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kafil</LastName><ForeName>Tahir S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>D Ian</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: dpaterson@ottawaheart.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04525404</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Can J Cardiol</MedlineTA><NlmUniqueID>8510280</NlmUniqueID><ISSNLinking>0828-282X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>Apr&#xe8;s le premier cas confirm&#xe9; en 2019, la COVID-19 s&#x2019;est rapidement propag&#xe9;e dans le monde entier et a submerg&#xe9; le milieu m&#xe9;dical. Entre-temps, les manifestations cliniques de la COVID-19 ont &#xe9;t&#xe9; comprises et des traitements efficaces, notamment des vaccins pr&#xe9;ventifs, ont &#xe9;t&#xe9; mis au point. Une COVID-19 grave est associ&#xe9;e &#xe0; de nombreux troubles cardiovasculaires lors de la phase aigu&#xeb;. Les patients gu&#xe9;ris de la maladie peuvent &#xe9;galement pr&#xe9;senter des s&#xe9;quelles &#xe0; long terme, notamment la COVID-19 de longue dur&#xe9;e. En outre, les vaccins &#xe0; ARN messager (ARNm) contre le coronavirus du syndrome respiratoire aigu s&#xe9;v&#xe8;re 2 (SRAS-CoV-2) peuvent d&#xe9;clencher de rares cas de myop&#xe9;ricardite. D&#x2019;importants progr&#xe8;s ont &#xe9;t&#xe9; r&#xe9;alis&#xe9;s dans la compr&#xe9;hension des complications cardiovasculaires aigu&#xeb;s et &#xe0; long terme de la myocardite associ&#xe9;e aux vaccins &#xe0; ARNm et &#xe0; la COVID-19 gr&#xe2;ce &#xe0; des &#xe9;tudes cliniques et approfondies utilisant l&#x2019;imagerie cardiaque. Dans cette synth&#xe8;se, nous d&#xe9;crivons comment l&#x2019;imagerie cardiovasculaire peut &#xea;tre utilis&#xe9;e pour comprendre les complications cardiovasculaires et les l&#xe9;sions cardiaques associ&#xe9;es &#xe0; une forme aigu&#xeb; de COVID-19, traitons des r&#xe9;sultats d&#x2019;imagerie chez les patients gu&#xe9;ris de la maladie et abordons le r&#xf4;le et des limites de l&#x2019;imagerie cardiaque dans la myocardite associ&#xe9;e aux vaccins &#xe0; ARNm et &#xe0; la COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36731604</ArticleId><ArticleId IdType="pmc">PMC9886397</ArticleId><ArticleId IdType="doi">10.1016/j.cjca.2023.01.022</ArticleId><ArticleId IdType="pii">S0828-282X(23)00068-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lala A., Johnson K.W., Januzzi J.L., et al. Prevalence and impact of myocardial injury in patients hospitalised with COVID-19 infection. J&#xa0;Am Coll Cardiol. 2020;76:533&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Changal K., Veria S., Mack S., et al. Myocardial injury in hospitalised COVID-19 patients: a retrospective study, systematic review, and meta-analysis. BMC Cardiovasc Disord. 2021;21:626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719604</ArticleId><ArticleId IdType="pubmed">34972516</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisi-Estabragh Z., Cooper J., Salih A., et al. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart. 2022;109:119&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9811071</ArticleId><ArticleId IdType="pubmed">36280346</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira V.M., Schulz-Menger J., Holmvang G., et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J&#xa0;Am Coll Cardiol. 2018;72:3158&#x2013;3176.</Citation><ArticleIdList><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasitlumkum N., Chokesuwattanaskul R., Thongprayoon C., et al. Incidence of myocardial injury in COVID-19&#x2013;infected patients: a systematic review and meta-analysis. Diseases. 2020;8:40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7709098</ArticleId><ArticleId IdType="pubmed">33120956</ArticleId></ArticleIdList></Reference><Reference><Citation>Parohan M., Yaghoubi S., Seraji A. Cardiac injury is associated with severe outcome and death in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Eur Heart J Acute Cardiovasc Care. 2020;9:665&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7678334</ArticleId><ArticleId IdType="pubmed">32567326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y., Chen T., Mui D., et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106:1132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211105</ArticleId><ArticleId IdType="pubmed">32354800</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles N.E., Ni J., Kearney D.L., et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J&#xa0;Am Coll Cardiol. 2003;42:466&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">12906974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B., Das S.R., Addison D., et al. 2022 AHA/ACC key data elements and definitions for cardiovascular and noncardiovascular complications of COVID-19: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circ Cardiovasc Qual Outcomes. 2022;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9297692</ArticleId><ArticleId IdType="pubmed">35737748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati E., Lupi L., Palazzini M., et al. Prevalence, characteristics, and outcomes of COVID-19&#x2013;associated acute myocarditis. Circulation. 2022;145:1123&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989611</ArticleId><ArticleId IdType="pubmed">35404682</ArticleId></ArticleIdList></Reference><Reference><Citation>Castiello T., Georgiopoulos G., Finocchiaro G., et al. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail Rev. 2022;27:251&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7988375</ArticleId><ArticleId IdType="pubmed">33761041</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels C.J., Rajpal S., Greenshields J.T., et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol. 2021;6:1078&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurus S., Weckbach L.T., Marschner C., et al. Differences in cardiac magnetic resonance imaging markers between patients with COVID-19&#x2013;associated myocardial injury and patients with clinically suspected myocarditis. J&#xa0;Thorac Imaging. 2021;36:279&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">34108409</ArticleId></ArticleIdList></Reference><Reference><Citation>Fronza M., Thavendiranathan P., Chan V., et al. Myocardial injury pattern at MRI in COVID-19 vaccine&#x2013;associated myocarditis. Radiology. 2022;304:553&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8856022</ArticleId><ArticleId IdType="pubmed">35166587</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontone G., Scafuri S., Mancini M.E., et al. Role of computed tomography in COVID-19. J&#xa0;Cardiovasc Comput Tomogr. 2021;15:27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473149</ArticleId><ArticleId IdType="pubmed">32952101</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefi-Koma A., Naghashzadeh F., Figtree G.A., Patel S., Karimi Galougahi K. Multi-modality imaging of inflammation and ischemia for assessment of myocardial injury in Covid-19. J&#xa0;Nucl Cardiol. 2021;28:3100&#x2013;3103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304658</ArticleId><ArticleId IdType="pubmed">32562192</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluckman T.J., Bhave N.M., Allen L.A., et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J&#xa0;Am Coll Cardiol. 2022;79:1717&#x2013;1756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichhorn C., Greulich S., Bucciarelli-Ducci C., et al. Multiparametric cardiovascular magnetic resonance approach in diagnosing, monitoring, and prognostication of myocarditis. JACC Cardiovasc Imaging. 2022;15:1325&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pubmed">35592889</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y., Lichter Y., Taieb P., et al. Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Circulation. 2020;142:342&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Faridi K.F., Hennessey K.C., Shah N., et al. Left ventricular systolic function and inpatient mortality in patients hospitalised with coronavirus disease 2019 (COVID-19) J&#xa0;Am Soc Echocardiogr. 2020;33:1414&#x2013;1415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442910</ArticleId><ArticleId IdType="pubmed">32951969</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberato S.H., Bruneto E.G., Reis G.S., et al. Abnormal echocardiographic findings in hospitalised patients with covid-19: a systematic review and meta-analysis. Arq Bras Cardio. 2022;119:267&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363071</ArticleId><ArticleId IdType="pubmed">35830075</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo F., Corredor C., Fletcher N., et al. Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: a systematic review and meta-analysis. Crit Care. 2018;22:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091069</ArticleId><ArticleId IdType="pubmed">30075792</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Kim Y., Pereira J., et al. Understanding the role of left and right ventricular strain assessment in patients hospitalised with COVID-19. Am Heart J Plus. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168299</ArticleId><ArticleId IdType="pubmed">34095889</ArticleId></ArticleIdList></Reference><Reference><Citation>Nambiar L., Volodarskiy A., Tak K.A., et al. Acute COVID-19&#x2013;associated decrements in left and right ventricular function predict all-cause mortality. J&#xa0;Am Soc Echocardiogr. 2022;35:229&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8496907</ArticleId><ArticleId IdType="pubmed">34627973</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghidini S., Gasperetti A., Winterton D., et al. Echocardiographic assessment of the right ventricle in COVID-19: a systematic review. Int J Cardiovasc Imaging. 2021;37:3499&#x2013;3512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8295549</ArticleId><ArticleId IdType="pubmed">34292433</ArticleId></ArticleIdList></Reference><Reference><Citation>Martha J.W., Pranata R., Wibowo A., Lim M.A. Tricuspid annular plane systolic excursion (TAPSE) measured by echocardiography and mortality in COVID-19: a systematic review and meta-analysis. Int J Infect Dis. 2021;105:351&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877816</ArticleId><ArticleId IdType="pubmed">33582370</ArticleId></ArticleIdList></Reference><Reference><Citation>Wats K., Rodriguez D., Prins K.W., et al. Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients. Pulm Circ. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060770</ArticleId><ArticleId IdType="pubmed">33959257</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon Z., Levi N., Orlev A., et al. The utility of handheld cardiac and lung ultrasound in predicting outcomes of hospitalised patients with COVID-19. Can J Cardiol. 2022;38:338&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8641404</ArticleId><ArticleId IdType="pubmed">34871728</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B.H., Shi N.N., Wu C.W., et al. Early cardiac involvement in patients with acute COVID-19 infection identified by multiparametric cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging. 2021;22:844&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989521</ArticleId><ArticleId IdType="pubmed">33686389</ArticleId></ArticleIdList></Reference><Reference><Citation>Caliskan M., Baycan O.F., Celik F.B., et al. Coronary microvascular dysfunction is common in patients hospitalised with COVID-19 infection. Microcirculation. 2022;29</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115225</ArticleId><ArticleId IdType="pubmed">35437863</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakos S., Chatzantonis G., Bietenbeck M., et al. A&#xa0;cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients. Sci Rep. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8329060</ArticleId><ArticleId IdType="pubmed">34341436</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavraganis G., Dimopoulou M., Delialis D., et al. Clinical implications of vascular dysfunction in acute and convalescent COVID-19: a systematic review. Eur J Clin Invest. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9539033</ArticleId><ArticleId IdType="pubmed">35986716</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianconi V., Mannarino M.R., Figorilli F., et al. Low brachial artery flow-mediated dilation predicts worse prognosis in hospitalised patients with COVID-19. J&#xa0;Clin Med. 2021;10:5456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621380</ArticleId><ArticleId IdType="pubmed">34830738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S., Aphinyanaphongs Y., Jones S., et al. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324:799&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I., Fonseca-Rodr&#xed;guez O., Farrington P., Lindmark K., Fors Connolly A.M. Risk of acute myocardial infarction and ischemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398:599&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8321431</ArticleId><ArticleId IdType="pubmed">34332652</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud E., Dauerman H.L., FGP Welt, et al. Management of acute myocardial infarction during the COVID-19 pandemic. Catheter Cardiovasc Interv. 2020;96:336&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">32311816</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta Y.S., Finkelstein M., Manna S., et al. Coronary artery calcification in COVID-19 patients: an imaging biomarker for adverse clinical outcomes. Clin Imaging. 2021;77:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875715</ArticleId><ArticleId IdType="pubmed">33601125</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann G.S., Fingerle A.A., Muller-Leisse C., et al. Coronary calcium scoring assessed on native screening chest CT imaging as predictor for outcome in COVID-19: an analysis of a hospitalised German cohort. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773182</ArticleId><ArticleId IdType="pubmed">33378410</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Canada. Frequency and impact of longer-term symptoms following COVID-19 in Canadian adults. October 20, 2022. Available at: https://health-infobase.canada.ca/covid-19/post-covid-condition/. Accessed November 4, 2022.</Citation></Reference><Reference><Citation>Gherbesi E., Bergamaschi L., Cusmano I., et al. The usefulness of speckle tracking echocardiography in identifying subclinical myocardial dysfunction in young adults recovered from mild COVID-19. Echocardiography. 2022;39:1190&#x2013;1197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9353365</ArticleId><ArticleId IdType="pubmed">35906710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai W., Raman B., Petersen S.E., et al. Longitudinal changes of cardiac and aortic imaging phenotypes following COVID-19 in the UK Biobank cohort. medRxiv. 2021 doi: 10.1101/2021.11.04.21265918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.04.21265918</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonow R.O., Yancy C.W. Explanation for the corrections for the study of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019. JAMA Cardiol. 2020;5:1308.</Citation><ArticleIdList><ArticleId IdType="pubmed">32840577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T., Knight D.S., Razvi Y., et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42:1866&#x2013;1878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S., Azuma M., Fukui K., et al. Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis. Heart Vessels. 2022;37:1570&#x2013;1582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8925980</ArticleId><ArticleId IdType="pubmed">35294611</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambadiari V., Mitrakou A., Kountouri A., et al. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection. Eur J Heart Fail. 2021;23:1916&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426810</ArticleId><ArticleId IdType="pubmed">34415085</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans P.C., Rainger G.E., Mason J.C., et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res. 2020;116:2177&#x2013;2184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A.I., Saad J.M., Han Y., et al. Coronary microvascular health in patients with prior COVID-19 infection. JACC Cardiovasc Imaging. 2022;12:2153&#x2013;2155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385193</ArticleId><ArticleId IdType="pubmed">36481086</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahony L., Buwalda T., Blair M., et al. Impact of long COVID on health and quality of life. HRB Open Res. 2022;5:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9440374</ArticleId><ArticleId IdType="pubmed">36101871</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Martin S., Shchendrygina A., et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022;28:2117&#x2013;2123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorecka M., Jex N., Thirunavukarasu S., et al. Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: a prospective case-control study. J&#xa0;Cardiovasc Magn Reson. 2022;24:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9464490</ArticleId><ArticleId IdType="pubmed">36089591</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Wang X., Song G. Association of epicardial adipose tissue with the severity and adverse clinical outcomes of COVID-19: A meta-analysis. Int J Infect Dis. 2022;120:33&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8996473</ArticleId><ArticleId IdType="pubmed">35421580</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell-Wiley T.M., Poirier P., Burke L.E., et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143:e984&#x2013;1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8493650</ArticleId><ArticleId IdType="pubmed">33882682</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Luk A., Clarke B., Dahdah N., et al. Myocarditis and pericarditis after COVID-19 mRNA vaccination: practical considerations for care providers. Can J Cardiol. 2021;37:1629&#x2013;1634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8349442</ArticleId><ArticleId IdType="pubmed">34375696</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong H.L., Hu M., Zhou C.K., et al. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases. Lancet. 2022;399:2191&#x2013;2199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9183215</ArticleId><ArticleId IdType="pubmed">35691322</ArticleId></ArticleIdList></Reference><Reference><Citation>Block J.P., Boehmer T.K., Forrest C.B., et al. Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination&#x2014;PCORnet, United States, January 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71:517&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989373</ArticleId><ArticleId IdType="pubmed">35389977</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymans S., Cooper L.T. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat Rev Cardiol. 2022;19:75&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8656440</ArticleId><ArticleId IdType="pubmed">34887571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B., Kamat I., Hotez P.J. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144:471&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340726</ArticleId><ArticleId IdType="pubmed">34281357</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlstad &#xd8;., Hovi P., Husby A., et al. SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents. JAMA Cardiol. 2022;7:600&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9021987</ArticleId><ArticleId IdType="pubmed">35442390</ArticleId></ArticleIdList></Reference><Reference><Citation>Sexson Tejtel S.K., Munoz F.M., Al-Ammouri I., et al. Myocarditis and pericarditis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2022;40:1499&#x2013;1511.</Citation><ArticleIdList><ArticleId IdType="pubmed">35105494</ArticleId></ArticleIdList></Reference><Reference><Citation>Luetkens J.A., Faron A., Isaak A., et al. Comparison of original and 2018 Lake Louise Criteria for diagnosis of acute myocarditis: results of a validation cohort. Radiol Cardiothorac Imaging. 2019;1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7978026</ArticleId><ArticleId IdType="pubmed">33778510</ArticleId></ArticleIdList></Reference><Reference><Citation>Dec G.W. How should we diagnose myocarditis, and is its recognition really clinically relevant? J&#xa0;Am Coll Cardiol. 2016;67:1812&#x2013;1814.</Citation><ArticleIdList><ArticleId IdType="pubmed">27081021</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong D.T., Dionne A., Muniz J.C., et al. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination. Circulation. 2022;145:345&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">34865500</ArticleId></ArticleIdList></Reference><Reference><Citation>Amemiya K., Kobayashi T., Kataoka Y., et al. Myocarditis after COVID-19 mRNA vaccination in three young adult males: significance of biopsy in vaccine-associated myocarditis. Pathol Int. 2022;72:385&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9347403</ArticleId><ArticleId IdType="pubmed">35583173</ArticleId></ArticleIdList></Reference><Reference><Citation>Paddock C.D., Reagan-Steiner S., Su J.R., et al. Autopsy histopathologic cardiac findings in 2 adolescents following the second COVID-19 vaccine dose. Arch Pathol Lab Med. 2022;146:921&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">35395076</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankstein R., Waller A.H. Evaluation of known or suspected cardiac sarcoidosis. Circ Cardiovasc Imaging. 2016;9</Citation><ArticleIdList><ArticleId IdType="pubmed">26926267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilonze O.J., Guglin M.E. Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021. Heart Fail Rev. 2022;27:2033&#x2013;2043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9023259</ArticleId><ArticleId IdType="pubmed">35449353</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshavarz P., Yazdanpanah F., Emad M., et al. Myocarditis following COVID-19 vaccination: cardiac imaging findings in 118 studies. Tomography. 2022;8:1959&#x2013;1973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9416085</ArticleId><ArticleId IdType="pubmed">36006062</ArticleId></ArticleIdList></Reference><Reference><Citation>Viskin D., Topilsky Y., Aviram G., et al. Myocarditis associated with COVID-19 vaccination: echocardiography, cardiac tomography, and magnetic resonance imaging findings. Circ Cardiovasc Imaging. 2021;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478100</ArticleId><ArticleId IdType="pubmed">34428917</ArticleId></ArticleIdList></Reference><Reference><Citation>Samimisedeh P., Jafari Afshar E., Shafiabadi Hassani N., Rastad H. Cardiac MRI findings in COVID-19 vaccine&#x2013;related myocarditis: a pooled analysis of 468 patients. J&#xa0;Magn Reson Imaging. 2022;56:971&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9348186</ArticleId><ArticleId IdType="pubmed">35612967</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadley S.M., Prakash A., Baker A.L., et al. Follow-up cardiac magnetic resonance in children with vaccine-associated myocarditis. Eur J Pediatr. 2022;181:2879&#x2013;2883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046711</ArticleId><ArticleId IdType="pubmed">35482094</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa Alhussein M., Rabbani M., Sarak B., et al. Natural history of myocardial injury after COVID-19 vaccine&#x2013;associated myocarditis. Can J Cardiol. 2022;38:1676&#x2013;1683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356639</ArticleId><ArticleId IdType="pubmed">35944800</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiyovich A., Plakht Y., Witberg G., et al. Myocarditis following COVID-19 vaccination. JACC Cardiovasc Imaging. 2022;15:2006&#x2013;2007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9568434</ArticleId><ArticleId IdType="pubmed">36357141</ArticleId></ArticleIdList></Reference><Reference><Citation>Schauer J., Buddhe S., Gulhane A., et al. Persistent cardiac magnetic resonance imaging findings in a cohort of adolescents with post-coronavirus disease 2019 mRNA vaccine myopericarditis. J&#xa0;Pediatr. 2022;245:233&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957353</ArticleId><ArticleId IdType="pubmed">35351530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.H., Kong E.J. FDG PET/MRI of acute myocarditis after mRNA COVID-19 vaccination. Clin Nucl Med. 2022;47:e421&#x2013;e422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983619</ArticleId><ArticleId IdType="pubmed">35234199</ArticleId></ArticleIdList></Reference><Reference><Citation>Asch F.M., Descamps T., Sarwar R., et al. Human vs artificial intelligence&#x2013;based echocardiographic analysis as a predictor of outcomes: an analysis from the World Alliance Societies of Echocardiography COVID Study. J&#xa0;Am Soc Echocardiogr. 2022;35:1226&#x2013;1237.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9293371</ArticleId><ArticleId IdType="pubmed">35863542</ArticleId></ArticleIdList></Reference><Reference><Citation>Meadus W.Q., Stobbe R.W., Grenier J.G., Beaulieu C., Thompson R.B. Quantification of lung water density with UTE Yarnball MRI. Magn Reson Med. 2021;86:1330&#x2013;1344.</Citation><ArticleIdList><ArticleId IdType="pubmed">33811679</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson R.B., Chow K., Mager D., Pagano J.J., Grenier J. Simultaneous proton density fat-fraction and R2&#x2217; imaging with water-specific T1 mapping (PROFIT1): application in liver. Magn Reson Med. 2021;85:223&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">32754942</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>